We design and execute immunology cell-based assays that give you clear, functional insights into your drug candidate. Whether you need to understand mechanism of action, measure potency, or predict immune-related safety, our assays provide data you can trust to make confident decisions.
Explore our innovative immune cell assays and platforms, offering tailored solutions to drive your research forward with precision and reliability.
Our scientists combine deep immunology expertise with advanced cell engineering capabilities to create bespoke, reproducible systems that mirror human biology. Every assay is designed to help you select and optimize the most promising therapeutic candidates faster and with greater confidence.
RoukenBio’s in vitro assay development portfolio supports functional characterization, in vitro pharmacology, and safety assessment across a range of therapeutic areas, including immuno-oncology, inflammation, allergy and autoimmunity.
Gain more translational results before moving in vivo. Our patient explants and 3D cell systems recreate the complexity of human tissue, helping you evaluate efficacy and behavior in a physiologically relevant environment.
Understand how your therapeutic candidates interact with human immune cell subsets. Using PBMCs and whole blood from healthy and disease state donors, our assays provide data on binding, functionality, efficacy, safety, selectivity, and mechanisms of action.
De-risk your drug development pipeline early. We identify potential immune activation or cytokine release risks using predictive in vitro systems, supporting safer and faster progression to the clinic.
Validate quality with confidence. Our detailed biophysical and cell based analyses confirm functionality, activity, and comparability throughout development and manufacturing.
As a global pharmaceutical contract research organization, RoukenBio provides drug development services to the vast scientific network worldwide. Our scientific partners are based mainly in the USA—particularly in Massachusetts (Boston, Cambridge) and California (San Francisco and San Diego)—Canada (from Vancouver up to Seattle), the UK, and Europe.
Difficulty doesn’t deter us; it inspires us. Give us a problem, and we’ll find your solution. Explore our cell-based assay development capabilities and assay portfolio in our Capabilities brochure.
